期刊
METABOLIC ENGINEERING
卷 31, 期 -, 页码 74-83出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymben.2015.06.010
关键词
Synthetic biology; Plant alkaloids; Yeast
资金
- National Institutes of Health [AT007886]
- National Science Foundation [CBET-1066100]
- Bill and Melinda Gates Foundation [OPP1058690]
- ARCS Foundation
- Stanford University
- Bill and Melinda Gates Foundation [OPP1058690] Funding Source: Bill and Melinda Gates Foundation
- Directorate For Engineering
- Div Of Chem, Bioeng, Env, & Transp Sys [1066100] Funding Source: National Science Foundation
Microbial biosynthesis for plant based natural products, such as the benzylisoquinoline alkaloids (BIAs), has the potential to address limitations in plant-based supply of established drugs and make new molecules available for drug discovery. While yeast strains have been engineered to produce a variety of downstream BIAs including the opioids, these strains have relied on feeding an early BIA substrate. We describe the de novo synthesis of the major BlA branch point intermediate reticuline via norcoclaurine in Saccharomyces cerevisiae. Modifications were introduced into yeast central metabolism to increase supply of the BIA precursor tyrosine, allowing us to achieve a 60-fold increase in production of the early benzylisoquinoline scaffold horn fed dopamine with no supply of exogenous tyrosine. Yeast strains further engineered to express a mammalian tyrosine hydroxylase, four mammalian tetrahydrobiopterin biosynthesis and recycling enzymes, and a bacterial DOPA decarboxylase produced norcoclaurine de nova We further increased production of early benzylisoquinoline scaffolds by 160-fold through introducing mutant tyrosine hydroxylase enzymes, an optimized plant norcoclaurine synthase variant, and optimizing culture conditions. Finally, we incorporated five additional plant enzymes - three methyltransferases, a cytochrome P450, and its reductase partner - to achieve de nova production of the key branch point molecule reticuline with a titer of 19.2 mu g/L. These strains and reconstructed pathways will serve as a platform for the biosynthesis of diverse natural and novel BIAs. (C) 2015 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据